3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
21
Other hematologic neoplasm
10
Plasma cell
4
Myeloid
4
Genitourinary
4
Dermatologic
2
Thoracic
1
Sarcoma
1
Other neoplasm
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Sarcoma
960
Glioblastoma
299
Gliosarcoma
288
Osteosarcoma
286
Brain Neoplasms
195
Dendritic Cell Sarcoma, Interdigitating
188
Gastrointestinal Stromal Tumors
180
Bone Neoplasms
172
Lymphoma
161
Central Nervous System Neoplasms
160
Astrocytoma
155
Sarcoma, Ewing
151
Glioma
149
Precursor Cell Lymphoblastic Leukemia-Lymphoma
147
Lymphoma, Non-Hodgkin
143
Burkitt Lymphoma
139
Neoplasms
137
Recurrence
134
Lymphoma, Large B-Cell, Diffuse
128
Lymphoma, Follicular
128
Rhabdomyosarcoma
126
Neuroblastoma
126
Hodgkin Disease
124
Oligodendroglioma
123
Breast Neoplasms
123
Lymphoma, Mantle-Cell
117
Leukemia, Myeloid, Acute
117
Leukemia, Lymphocytic, Chronic, B-Cell
117
Lymphoma, B-Cell, Marginal Zone
113
Leukemia
111
Interventions
pembrolizumab
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Immune System Diseases
×
Sarcoma
×
Clear all
NCT03349450
2026-05-06
SPiReL
Sunnybrook Health Sciences Centre
Phase 2
Completed
25 enrolled
18 charts